Skip to main content
Retour
Watch Compare

CervoMed Inc.

Qualité des données : 100%
CRVO
Nasdaq Manufacturing Chemicals
3,83 €
▼ 0,20 € (-4,96%)
Cap. Boursière: 37,03 M
Prix
4,00 €
Cap. Boursière
37,03 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -23,45 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-58,86%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-90,72%
En dessous de la moyenne du secteur (-53,53%)
ROIC-65,08%
Net Margin-673,06%
Op. Margin-706,22%

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valorisation

PE (TTM)
-1,37
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,42
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -1,4 -1,5
P/B 1,4 1,6
ROE % -90,7 -53,5
Net Margin % -673,1 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

7 analystes
Buy
Actuel
3,83 €
+478.1%
Objectif
22,14 €
11,00 €
21,00 €
31,00 €
Prévisions
P/E Prévisionnel -2,26
BPA Prévisionnel -1,69 €
CA Est. 625 000,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -1,69 €
-2,44 € – -0,34 €
 625 000,0 6
FY2026 -2,38 €
-4,34 € – -0,54 €
 350 000,0 7

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,70 € -0,88 € -25,4%
Q32025 -0,64 € -0,84 € -31,6%
Q22025 -0,62 € -0,70 € -13,3%
Q12025 -0,62 € -0,56 € +10,2%

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -58,86% Revenue Growth (3Y) -25,12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,01 M Net Income (TTM) -26,97 M
ROE -90,72% ROA -78,51%
Gross Margin N/A Operating Margin -706,22%
Net Margin -673,06% Free Cash Flow (TTM) -23,45 M
ROIC -65,08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 0,12
Working Capital N/A Tangible Book Value 26,01 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,37 Forward P/E N/A
P/B Ratio 1,42 P/S Ratio 9,24
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -63,32%
Market Cap 37,03 M Enterprise Value 27,60 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,43
FCF / Share -2,53 OCF / Share -2,53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86,96%
SBC-Adj. FCF -24,87 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,01 M 9,74 M 7,14 M — —
Net Income -26,97 M -16,29 M -2,17 M -15,59 M -24,10 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -28,29 M -18,23 M -7,81 M -15,97 M -24,68 M
EBITDA — — — — —
R&D Expenses 21,82 M 18,80 M 8,44 M 7,24 M 8,50 M
SG&A Expenses — — — — —
D&A — — — 0,0 93 416,0
Interest Expense — — 0,0 — —
Income Tax 0,0 — — 0,0 -443 893,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 22,88 M 43,08 M 9,97 M 22,64 M 37,84 M
Total Liabilities 4,66 M 3,88 M 2,60 M 2,42 M 2,93 M
Shareholders' Equity 18,22 M 39,20 M 7,38 M 20,22 M 34,91 M
Total Debt — — — — —
Cash & Equivalents 8,24 M 9,00 M 7,79 M 10,11 M 37,31 M
Current Assets 22,88 M 43,08 M 9,96 M 22,64 M 37,82 M
Current Liabilities 4,66 M — — — 2,93 M